Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 103
Diğer Dergilerde Yayınlanan Makaleler 19
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 71

3. Evaluation of Set-Up Position Changes During Online Adaptive Therapy

The European Society for Radiotherapy and Oncology (ESTRO), Glasgow, İngiltere, 3 - 07 Mayıs 2024, cilt.194, ss.4353-4354, (Özet Bildiri) Creative Commons License

4. Dosimetric Comparision of VMAT and HyperArc Techniques for Multiple Brain Metastasis

The European Society for Radiotherapy and Oncology (ESTRO)2024, Glasgow, İngiltere, 3 - 07 Mayıs 2024, cilt.194, ss.3524-3525, (Özet Bildiri) Creative Commons License

7. Akciğer Tümörlerinin Tedavisinde MR Kılavuzluğunda Online Adaptif Radyoterapi

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.49, (Özet Bildiri)

8. MRGRT: Neden Adapte Ediyoruz

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.53-54, (Özet Bildiri)

10. Adrenal Bez Metastazlarının Tedavisinde Stereotaktik Mr Kılavuzluğunda Adaptif Radyoterapi

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.99, (Özet Bildiri)

11. Prostat Kanseri Tedavisinde MR Kılavuzluğunda Online Adaptif Stereotaktik Vücut Radyoterapisi

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.14, (Özet Bildiri)

12. Vajinal Karsinomda Brakiterapinin Yeri

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, cilt.1, sa.1, ss.1, (Özet Bildiri)

13. Nüks yüksek dereceli glioma hastalarında yeniden ışınlama sonuçları

15.Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, cilt.1, sa.1, ss.1, (Özet Bildiri)

16. Stereotactic MR-guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Liver Metastases in Oligometastatic Patients

2023 Radiosurgery Society Meeting, Florida, Amerika Birleşik Devletleri, 23 - 25 Mart 2023, cilt.15, ss.903, (Özet Bildiri)

17. Stereotactic Body Radiotherapy (SBRT) for Multiple (≥3) Synchronous/Metachronous Lung Metastasis

2023 Radiosurgery Society Meeting, Florida, Amerika Birleşik Devletleri, 23 - 25 Mart 2023, cilt.15, sa.4, ss.890, (Özet Bildiri)

20. ATİPİK TERATOİD RABDOİD TÜMÖR: BEŞ OLGU SUNUMU

24. Ulusal Kanser Kongresi, İstanbul, Türkiye, 9 - 13 Kasım 2022, ss.32, (Özet Bildiri) Creative Commons License

21. PSA Kinetics and Outcomes after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy for Prostate Cancer

Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri) identifier

22. MR-Guided Online Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary and Metastatic Lung Tumors

Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri) identifier

32. Effect of Small Field Dosimetry on Stereotactic Radiosurgery Treatment Plans

AAPM Virtual Spring Clinical Meeting, Virginia, Amerika Birleşik Devletleri, 17 - 21 Nisan 2021, ss.3, (Özet Bildiri)

33. Treatment Results of Pediatric Posterior Fossa Ependymomas according to Molecular Subtypes

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri) identifier

34. Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

35. Time Analysis in Magnetic Resonance Image-Guided Radiotherapy Workflow

61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Illinois, Amerika Birleşik Devletleri, 15 - 18 Eylül 2019, cilt.105, (Özet Bildiri) identifier

36. IS THE PATHOLOGICAL-GRADE RELEVANT IN "IDH-WILD TYPE, TERT-MUTANT" DIFFUSE-GLIOMAS? AN ANALYSIS IN 147 PATIENTS

14th Meeting of the European-Association-of-Neuro-Oncology (EANO), Lyon, Fransa, 19 - 22 Eylül 2019, cilt.21, ss.90, (Özet Bildiri) Creative Commons License identifier

37. Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, İtalya, 26 - 30 Nisan 2019, cilt.133, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

38. Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TROG)

60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 21 - 24 Ekim 2018, cilt.102, (Özet Bildiri) identifier

39. Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial

37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, İspanya, 20 - 24 Nisan 2018, cilt.127, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

40. Short vs protracted urethra-sparing prostate SBRT: feasibility and early toxicity from a randomized phase II trial

19th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Basel, İsviçre, 11 - 13 Haziran 2015, cilt.191, ss.902, (Özet Bildiri) identifier

42. Comparison of Target Volume and Organ at Risk Doses With Multichannel Versus Single Channel Cylinder for Vaginal Brachytherapy

56th Annual Meeting of the American-Society-for-Radiation-Oncology, San-Francisco, Kostarika, 14 - 17 Eylül 2014, cilt.90, (Özet Bildiri) identifier

44. Head and Neck IMRT With or Without Flattening Filter: A Dosimetric Comparison

54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, Amerika Birleşik Devletleri, 28 - 31 Ekim 2012, cilt.84, (Özet Bildiri) identifier

45. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) identifier

47. QUALITY OF LIFE RESULTS OF AN EORTC PHASE III RANDOMIZED TRIAL OF ADJUVANT WHOLE-BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES OF SOLID TUMORS

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2010, cilt.12, ss.101, (Özet Bildiri) identifier

48. RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN ELDERLY GLIOBLASTOMA PATIENTS: PERFORMANCE OR AGE AS A SURROGATE?

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2010, cilt.12, ss.42, (Özet Bildiri) identifier

50. SINGLE CENTER SURVIVAL OUTCOMES OF 167 GLIOBLASTOMA PATIENTS: BEFORE AND AFTER TEMOZOLOMIDE

3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Yokohama, Japonya, 11 - 14 Mayıs 2009, cilt.11, ss.936, (Özet Bildiri) identifier

51. WHOLE-BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGERY OF 1-3 BRAIN METASTASES-RESULTS OF THE EORTC 22952-26001 PHASE III STUDY

3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Yokohama, Japonya, 11 - 14 Mayıs 2009, cilt.11, ss.899, (Özet Bildiri) identifier

52. ADJUVANT WHOLE BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES-RESULTS OF THE EORTC 22952-26001 STUDY

Joint Meeting of the Society-forNeuro-Oncology/American-Association-of-Neurological -Surgeons/Congress of Neurological Surgeons, Louisiana, Amerika Birleşik Devletleri, 22 - 24 Ekim 2009, cilt.11, ss.662-663, (Özet Bildiri) identifier

53. Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases - results of the EORTC 22952-26001 study

15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, cilt.7, ss.495, (Özet Bildiri) identifier

55. Effect of Time Interval between Surgical Resection and Radiotherapy on Survival of Patients with Glioblastoma

51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75, (Özet Bildiri) identifier

56. Adjuvant Whole Brain Radiotherapy vs. Observation after Radiosurgery or Surgical Resection of 1-3 Cerebral Metastases - Results of the EORTC 22952-26001 Study

51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75, (Özet Bildiri) identifier

57. Three dimensinal non coplanar irradiation for right hemitorasic tumors of operated malignant mesothelioma

9th Biennial Meeting on Physics and Radiation Technology for Clinical Radiotherapy, Barcelona, İspanya, 8 - 13 Eylül 2007, cilt.84, (Özet Bildiri) identifier

58. Assessment of toxicity and the factors limiting concomitant radiochemotherapy in squamous cell carcinoma of head and neck (HNSCC)

International Meeting on Innovative Approaches in Head and Neck Oncology, Barcelona, İspanya, 22 - 27 Şubat 2007, cilt.82, (Özet Bildiri) identifier

59. Information needs of early-stage prostate cancer patients: A comparison of seven European countries and Canada.

25th Congress of the European-Society-for-Therapeutic-Radiology-and-Oncology, Leipzig, Almanya, 8 - 12 Ekim 2006, cilt.81, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

62. Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.225-226, (Özet Bildiri) identifier

63. Treatment results of 165 pediatric patients with non metastatic nasopharyngeal carcinoma a rare cancer network study (sözlü sunum)

Proc. ECCO 13-the European Cancer Conference, Paris, France, 30 October-3 November (Sözlü sunum), 2005, Paris, Fransa, 30 Ekim - 03 Kasım 2005, cilt.3, ss.354, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

64. Treatment results of 165 pediatric patients with non metastatic nasopharyngeal carcinoma A rare cancer network study (sözlü sunum)

Proc. 47th Annual Meeting of the American Society of Therapeutic Radiology, Denver, Colorado, 16-20 October, 2005, Colorado, Amerika Birleşik Devletleri, 16 - 20 Ekim 2005, cilt.63, ss.23, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

66. Prognostic significance of MIB-1 labeling indices for oligodendroglial tumors

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri) identifier

67. Ki-67 proliferation index as a marker for clinical radioresponse in glioblastoma multiforme

47th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, Colorado, Amerika Birleşik Devletleri, 16 - 20 Ekim 2005, cilt.63, (Özet Bildiri) identifier

69. Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC).

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri) identifier

70. Is the incidence of anal canal cancers different in Moslem societies?

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri) identifier

71. The outcomes of patients with trigeminal Schwannoma after stereotactic radiosurgery

2nd ESTRO Meeting on Radiotherapy for Non-Malignant Diseases, Nice, Fransa, 1 - 03 Nisan 2004, cilt.71, (Özet Bildiri) identifier
Kitaplar 6

1. Moleküler görüntülemenin akciğer kanserli hastalarda radyoterapi planlaması ve tedavi yanıtının değerlendirilmesine katkısı

Akciğer Kanserlerinde Güncel Moleküler Görüntüleme Uygulamaları, Vardareli E, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.66-71, 2024

2. Ependimom tedavisinde güncel gelişmeler

Çocuk ve Ergenlerde Beyin Tümörleri: Güncel Yaklaşım, Kebudi R, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.57-62, 2022

3. Beyin Metastazlarında Yeniden Işınlama: Örnekler Üzerinden Hedef Hacim, Doz, Plan Öneriler

Yeniden Işınlama, Esra Kaytan Sağlam,Beste Atasoy, Editör, Kare Yayınları, İstanbul, ss.269-284, 2021

4. Yaşlı Santral Sinir Sistemi Tümörlü Hastalarda Radyoterapi

Erişkin Santral Sinir Sistemi Tümörleri, Perran Fulden Yumuk, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.39-42, 2019

5. Malign Beyin Tümörlerinde Stereotaktik Radyocerrahi ve Stereotaktik Radyoterapi

Stereotaktik Beden Radyoterapisi/Stereotaktik Radyocerrahi, Oral EN, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.62-67, 2018

6. Hematolojik ve non-hematolojşk malinitelerde protokoller

Hematolojik ve non-hematolojşk malinitelerde protokoller, Mustafa Çetiner, Editör, Yelken Basım Yayım, İstanbul, ss.1-159, 2007
Metrikler

Yayın

203

Yayın (WoS)

123

Yayın (Scopus)

75

Atıf (WoS)

4366

H-İndeks (WoS)

24

Atıf (Scopus)

5392

H-İndeks (Scopus)

27

Atıf (Scholar)

7499

H-İndeks (Scholar)

30

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Tez Danışmanlığı

7

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları